WS 11 - Quantitative Assessment of NASH Using Ultrasound: From Research to Routine Practice
March 1, 15:00 - 16:00 CET
Nonalcoholic fatty liver disease is affecting more than 25% of adults and has become a worldwide disease. It represents a major healthcare issue in most countries, and is extending to teenagers. Metabolic-associated fatty liver disease and Non-Alcoholic steato-hepatitis require development of non-invasive tools for diagnosis, screening and monitoring. Ultrasound imaging represents an ideal method due to its availability, cost and acceptability. However, measurements remained in the research domain because of technical limitations and limited reproducibility. These tools include stiffness and attenuation measurements. They are now reaching routine practice and provide reproducible and reliable quantification of liver fat deposition. These quantitative parameters can be acquired during routine US liver examination. Tips and tricks for optimal acquisition will be discussed, as well as up-to-date recommendations.